Hospital
Indiana University Health West Hospital INC
Indiana University Health West Hospital INC was paid $15.99M by Medicaid between Jan 2018 and Nov 2024, across 90 billing codes. Its largest line is 99283, emergency room visit (moderate) — 24% of everything it billed.
33Billing provider infoINDIANA UNIVERSITY HEALTH WEST HOSPITAL INC
AVON, IN 46123
AVON, IN 46123
33aNPI1063443455assigned 07/05/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$15.99M
24GClaims304,445
24DCodes billed90
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Indiana
Rank by total paid#25 of 69
Median peer was paid$9.76M
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 42,726 | $986K | |
| 2019 | 32,611 | $1.73M | |
| 2020 | 29,379 | $1.52M | |
| 2021 | 42,715 | $2.47M | |
| 2022 | 69,788 | $4.12M | |
| 2023 | 55,509 | $3.24M | |
| 2024incomplete | 31,717 | $1.93M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 24% | 22,842 | 20,910 | $3.77M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 21% | 22,500 | 20,094 | $3.36M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 19% | 23,153 | 19,996 | $3.00M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 7.7% | 18,787 | 16,053 | $1.23M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6.2% | 18,319 | 15,872 | $992K |
| 71046 | Radiologic examination, chest; 2 views | 5.3% | 7,452 | 6,606 | $843K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.5% | 4,935 | 4,479 | $394K |
| 71045 | Radiologic examination, chest; single view | 1.9% | 2,093 | 1,829 | $307K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.8% | 8,212 | 6,909 | $292K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.6% | 5,982 | 5,372 | $258K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.6% | 748 | 624 | $249K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | <1% | 1,344 | 746 | $154K |
78 more codes
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 27,266 | $129K |
| 36415 | Collection of venous blood by venipuncture | <1% | 29,561 | $116K |
| 87503 | <1% | 4,316 | $102K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,638 | $94K |
| 81025 | <1% | 14,958 | $79K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 16,789 | $74K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,405 | $62K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 1,060 | $58K |
| 85027 | <1% | 15,340 | $56K | |
| 84484 | <1% | 8,390 | $45K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 514 | $40K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 6,465 | $32K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 452 | $29K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 213 | $21K |
| 80076 | <1% | 4,086 | $21K | |
| 81001 | <1% | 11,760 | $20K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 305 | $20K |
| 80053 | Comprehensive metabolic panel | <1% | 3,471 | $19K |
| 59025 | Fetal non-stress test | <1% | 51 | $17K |
| 83690 | <1% | 4,942 | $17K | |
| 81003 | <1% | 8,345 | $12K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 215 | $9K |
| 64493 | <1% | 15 | $6K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 126 | $6K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,424 | $5K |
| 80348 | <1% | 64 | $5K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 246 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 101 | $4K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 187 | $4K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 32 | $4K |
| 80320 | <1% | 32 | $2K | |
| 73560 | <1% | 70 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 193 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 141 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 141 | $2K |
| 87276 | <1% | 267 | $2K | |
| 87275 | <1% | 267 | $2K | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | <1% | 12 | $2K |
| 64494 | <1% | 15 | $1K | |
| 73502 | <1% | 44 | $1K | |
| 80061 | Lipid panel | <1% | 129 | $1K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 59 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 73 | $996.35 |
| 83605 | <1% | 128 | $684.67 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 105 | $657.18 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 45 | $576.10 |
| 86140 | <1% | 95 | $378.07 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 40 | $353.52 |
| 84439 | <1% | 45 | $342.76 | |
| 83735 | <1% | 85 | $323.22 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 16 | $294.84 |
| 82607 | <1% | 29 | $294.63 | |
| 84702 | <1% | 22 | $216.76 | |
| 85379 | <1% | 27 | $192.96 | |
| 85014 | <1% | 223 | $108.21 | |
| 88142 | <1% | 25 | $84.96 | |
| 80047 | <1% | 44 | $69.04 | |
| 85652 | <1% | 29 | $62.69 | |
| 87660 | <1% | 12 | $48.04 | |
| 87480 | <1% | 12 | $48.04 | |
| 87510 | <1% | 12 | $48.04 | |
| 83615 | <1% | 13 | $33.58 | |
| 82948 | <1% | 18 | $29.78 | |
| 85018 | <1% | 12 | $26.07 | |
| 82330 | <1% | 25 | $18.66 | |
| 82565 | <1% | 25 | $12.28 | |
| 84295 | <1% | 25 | $11.53 | |
| 84132 | <1% | 25 | $11.02 | |
| 82947 | <1% | 25 | $10.66 | |
| 84520 | <1% | 25 | $9.46 | |
| 82374 | <1% | 25 | $9.12 | |
| 82435 | <1% | 25 | $9.12 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 84 | $0.00 |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | 0% | 13 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 236 | $0.00 |
| C1755 | Catheter, intraspinal | 0% | 277 | $0.00 |
| 80329 | 0% | 26 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPUCKETT, KENNETH (PRESIDENT)